A Double-Blind, Randomised, Placebo-Controlled Study Evaluating the Effects of a Novel Multi-Targeted Dermatologist-Formulated Oral Supplement on Skin, Hair, Sleep, Energy, Cognition, Libido, and Longevity
Trial registry update: ACTIVE_NOT_RECRUITING. No results reported in the supplied registry record.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 18, 2026 · Discovered: Sep 19, 2026 · Assessed: — · Research update
What it does not prove
- The abstract provides no numerical results, effect sizes, or p-values, making it impossible to assess whether observed differences were meaningful or statistically significant. The supplement contains multiple active ingredients beyond omega-3s alone, so any effects cannot be attributed to omega-3 fatty acids specifically. A 12-week timeframe cannot establish whether any short-term changes persist or predict longer-term health outcomes like longevity, despite the study's title.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- 3 months
- Population
- Healthy adults aged 35 to 65 years
- Primary outcome
- Skin condition (assessed by instrumental measurements, trained-assessor visual grading, and participant questionnaires)
- Effect size
- —
- Significance
- Not reported
- Journal
- IDI Skincare Limited
- Published
- Sep 18, 2026
Funding: Sponsored by IDI Skincare Limited; conducted by Eurofins Product Testing Services Ltd (trading as Eurofins Alba) in Edinburgh, United Kingdom
Conflicts: Study sponsored by the manufacturer of the intervention product (IDI Skincare Limited), which is a substantial conflict of interest
Sources
Primary source
- IDI Skincare Limited ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
This study evaluated the effects of a daily oral supplement regimen (Advanced ID Brain, Heart and Eye Omega Gel Capsules taken with Advanced ID Longevity and Collagen Complex Powder) on measures of skin condition, hair, sleep, energy, cognition and sexual wellbeing in healthy adults aged 35 to 65 years.
Participants were randomised in a 2:1 ratio to receive either the active supplement regimen or a matched placebo regimen once daily with food for 12 weeks.
Instrumental skin measurements, trained-assessor visual grading and participant questionnaires were performed at baseline (Day 0), Day 28 and Day 84. Hair imaging and cognitive testing were performed at baseline and Day 84.
The study was single-centre, sponsored by IDI Skincare Limited and conducted by Eurofins Product Testing Services Ltd (trading as Eurofins Alba) in Edinburgh, United Kingdom.
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.